Orgenesis Inc. Enters Material Definitive Agreement

Ticker: ORGS · Form: 8-K · Filed: Jul 8, 2024 · CIK: 1460602

Orgenesis INC. 8-K Filing Summary
FieldDetail
CompanyOrgenesis INC. (ORGS)
Form Type8-K
Filed DateJul 8, 2024
Risk Levelmedium
Pages2
Reading Time3 min
Key Dollar Amounts$2,000,000, $1,000,000
Sentimentneutral

Sentiment: neutral

Topics: material-definitive-agreement, financial-obligation

TL;DR

Orgenesis Inc. just signed a big deal creating a financial obligation.

AI Summary

On July 3, 2024, Orgenesis Inc. entered into a material definitive agreement, creating a direct financial obligation. The company, incorporated in Nevada with its principal executive offices in Germantown, MD, is involved in the pharmaceutical preparations industry.

Why It Matters

This filing indicates Orgenesis Inc. has entered into a significant agreement that will create a financial obligation for the company, potentially impacting its financial health and future operations.

Risk Assessment

Risk Level: medium — Entering into new material definitive agreements that create financial obligations can introduce financial risks and uncertainties for a company.

Key Players & Entities

FAQ

What is the nature of the material definitive agreement entered into by Orgenesis Inc.?

The filing states that Orgenesis Inc. entered into a material definitive agreement on July 3, 2024, which created a direct financial obligation or an obligation under an off-balance sheet arrangement.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on July 3, 2024.

In which state is Orgenesis Inc. incorporated?

Orgenesis Inc. is incorporated in Nevada.

What is the principal business address of Orgenesis Inc.?

The principal business address of Orgenesis Inc. is 20271 Goldenrod Lane, Germantown, MD 20876.

What is Orgenesis Inc.'s Standard Industrial Classification code?

Orgenesis Inc.'s Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.

Filing Stats: 721 words · 3 min read · ~2 pages · Grade level 11.7 · Accepted 2024-07-08 16:05:34

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ORGENESIS INC. Date: July 8, 2024 By: /s/ Victor Miller Victor Miller Chief Financial Officer, Treasurer and Secretary

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing